Late-Breaking Abstract 1: Randomized Phase Iii Noninferiority Trial of First Line Chemotherapy for Metastatic or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study
AuthID
P-00V-T93
P-00V-T93